Open original FDA record ↗Recall record
- FDA identifier
- Z-1701-2012
- Company in FDA record
- Siemens Healthcare Diagnostics
- FDA classification date
- Jun 2, 2012
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 17, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
Siemens Healthcare Diagnostics has observed a negative bias in the Immulite Insulin assay.
Source facts
- Action
- Siemens sent an Urgent Device Recall letter dated April 2012 via fax to affected U.S. customers and an Urgent Field Safety Notice to customers outside the U.S. The letter identified the affected kit lots, reason for voluntary recall, risk to health and actions to be taken by the customer/user. Customers were instructed to discard any inventory of the affected kit lots and complete and return the attached Field Correction Effectiveness Check questionnaire within thirty (30) days to request a no-charge replacement kits. Customers were requested to post this field correction by each IMMULITE system to alert users to the situation. For questions contact your Siemens Technical Solutions Center.
- Initiated
- 2012-04-30
- Root cause
- Component change control
- Terminated
- 2017-03-16
- Distribution
- Worldwide Distribution - US (nationwide)
- Recall number
- Z-1701-2012
- Recall status
- Terminated
- CDRH record ID
- 108934
- FDA classified
- 2012-06-02
- Recall event number
- 61755